BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9499384)

  • 21. Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T15.
    Cheng L; Tachibana K; Iwasaki H; Kameyama A; Zhang Y; Kubota T; Hiruma T; Tachibana K; Kudo T; Guo JM; Narimatsu H
    FEBS Lett; 2004 May; 566(1-3):17-24. PubMed ID: 15147861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth.
    Taniuchi K; Cerny RL; Tanouchi A; Kohno K; Kotani N; Honke K; Saibara T; Hollingsworth MA
    Oncogene; 2011 Dec; 30(49):4843-54. PubMed ID: 21625220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of acceptor site specificities for three members of UDP-GalNAc:N-acetylgalactosaminyltransferases by using a synthetic peptide mimicking the tandem repeat of MUC5AC.
    Tetaert D; Richet C; Gagnon J; Boersma A; Degand P
    Carbohydr Res; 2001 Jul; 333(2):165-71. PubMed ID: 11448678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. cDNA cloning and expression of a family of UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase sequence homologs from Caenorhabditis elegans.
    Hagen FK; Nehrke K
    J Biol Chem; 1998 Apr; 273(14):8268-77. PubMed ID: 9525933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. cDNA cloning and expression of a novel human UDP-N-acetyl-alpha-D-galactosamine. Polypeptide N-acetylgalactosaminyltransferase, GalNAc-t3.
    Bennett EP; Hassan H; Clausen H
    J Biol Chem; 1996 Jul; 271(29):17006-12. PubMed ID: 8663203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural basis of carbohydrate transfer activity by human UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase (pp-GalNAc-T10).
    Kubota T; Shiba T; Sugioka S; Furukawa S; Sawaki H; Kato R; Wakatsuki S; Narimatsu H
    J Mol Biol; 2006 Jun; 359(3):708-27. PubMed ID: 16650853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel human UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, GalNAc-T7, with specificity for partial GalNAc-glycosylated acceptor substrates.
    Bennett EP; Hassan H; Hollingsworth MA; Clausen H
    FEBS Lett; 1999 Oct; 460(2):226-30. PubMed ID: 10544240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conservation of peptide acceptor preferences between Drosophila and mammalian polypeptide-GalNAc transferase ortholog pairs.
    Gerken TA; Ten Hagen KG; Jamison O
    Glycobiology; 2008 Nov; 18(11):861-70. PubMed ID: 18669915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the UDP-N-acetylgalactosamine binding domain of bovine polypeptide alphaN-acetylgalactosaminyltransferase T1.
    Duclos S; Da Silva P; Vovelle F; Piller F; Piller V
    Protein Eng Des Sel; 2004 Aug; 17(8):635-46. PubMed ID: 15377782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic epigenetic regulation of initial O-glycosylation by UDP-N-Acetylgalactosamine:Peptide N-acetylgalactosaminyltransferases. site-specific glycosylation of MUC1 repeat peptide influences the substrate qualities at adjacent or distant Ser/Thr positions.
    Hanisch FG; Müller S; Hassan H; Clausen H; Zachara N; Gooley AA; Paulsen H; Alving K; Peter-Katalinic J
    J Biol Chem; 1999 Apr; 274(15):9946-54. PubMed ID: 10187769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The specificity of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase as inferred from a database of in vivo substrates and from the in vitro glycosylation of proteins and peptides.
    Elhammer AP; Poorman RA; Brown E; Maggiora LL; Hoogerheide JG; Kézdy FJ
    J Biol Chem; 1993 May; 268(14):10029-38. PubMed ID: 8486674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyl-transferase from the snail Biomphalaria glabrata - substrate specificity and preference of glycosylation sites.
    Taus C; Windwarder M; Altmann F; Grabherr R; Staudacher E
    Glycoconj J; 2014 Dec; 31(9):661-70. PubMed ID: 25338825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of flanking sequence on the O-glycosylation of threonine in vitro.
    O'Connell BC; Hagen FK; Tabak LA
    J Biol Chem; 1992 Dec; 267(35):25010-8. PubMed ID: 1460004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucin-type O-glycosylation in helminth parasites from major taxonomic groups: evidence for widespread distribution of the Tn antigen (GalNAc-Ser/Thr) and identification of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity.
    Casaravilla C; Freire T; Malgor R; Medeiros A; Osinaga E; Carmona C
    J Parasitol; 2003 Aug; 89(4):709-14. PubMed ID: 14533679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of O-linked glycosylation throughout the Golgi apparatus.
    Röttger S; White J; Wandall HH; Olivo JC; Stark A; Bennett EP; Whitehouse C; Berger EG; Clausen H; Nilsson T
    J Cell Sci; 1998 Jan; 111 ( Pt 1)():45-60. PubMed ID: 9394011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The participation of ribosome-UDP-GalNAc complex in the initiation of protein glycosylation in vitro.
    Paszkiewicz-Gadek A; Porowska H; Gindzieński A
    Acta Biochim Pol; 2000; 47(2):421-6. PubMed ID: 11051206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Site directed processing: role of amino acid sequences and glycosylation of acceptor glycopeptides in the assembly of extended mucin type O-glycan core 2.
    Brockhausen I; Dowler T; Paulsen H
    Biochim Biophys Acta; 2009 Oct; 1790(10):1244-57. PubMed ID: 19524017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification, cloning, and expression of a bovine UDP-GalNAc: polypeptide N-acetyl-galactosaminyltransferase.
    Hagen FK; Van Wuyckhuyse B; Tabak LA
    J Biol Chem; 1993 Sep; 268(25):18960-5. PubMed ID: 8360184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Function of the lectin domain of polypeptide N-acetylgalactosaminyltransferase 1.
    Tenno M; Kézdy FJ; Elhammer AP; Kurosaka A
    Biochem Biophys Res Commun; 2002 Nov; 298(5):755-9. PubMed ID: 12419318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human Immunodeficiency Virus and Simian Immunodeficiency Virus Maintain High Levels of Infectivity in the Complete Absence of Mucin-Type O-Glycosylation.
    Termini JM; Church ES; Silver ZA; Haslam SM; Dell A; Desrosiers RC
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28747495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.